Comments (32)

Jul 17, 2018 - 8:52am
SevroII, what's your opinion? Comment below:

PJT - probably the top shop on the street

Lazard / Evercore / HL - All very good and have solid deal flow and exits. Heard really good things about work life balance at HL

Millstein - heard really good things (comp was apparently top notch)/was up and coming but idk how the gugg acquisition changes things

Dec 27, 2018 - 1:59pm
MidMarketMcLovin, what's your opinion? Comment below:
SevroII:
PJT - probably the top shop on the street

Lazard / Evercore / HL - All very good and have solid deal flow and exits. Heard really good things about work life balance at HL

Millstein - heard really good things (comp was apparently top notch)/was up and coming but idk how the gugg acquisition changes things

I've heard of people being wheeled out of HL London by paramedics after collapsing. Former colleague who worked there had 2 free weekends in 3 years.

Jul 17, 2018 - 9:50am
tommyjeff1221, what's your opinion? Comment below:

What are some general personalities that work in RX? Aren't you dealing with some pretty tough situations?

John Downey
Controversial
Dec 22, 2018 - 11:34am
liverpoolfc2323, what's your opinion? Comment below:

As mentioned. Best analysts roles for Rx with top pay, prestige, and exits are PJT and EVR. Most well-known analyst programs that specialize in Rx are PJT/EVR/HL. HL also very good. Lazard's group is also great but the analyst role is M&A/Rx. Exits from all these groups are fantastic.

  • 16
  • 8
Dec 24, 2018 - 2:35pm
Davis97, what's your opinion? Comment below:

This is inaccurate regarding Lazard's program. They split their Industry (usually M&A) and Rx practices into separate groups, though sometimes a deal works through more than one group (e.g. I think the Toys bankruptcy was worked on by both the consumer and Rx groups). So the Rx analyst program is actually separate from M&A.

Dec 25, 2018 - 1:38am
jsmith17, what's your opinion? Comment below:

Clearly you work for EVR. No one lumps their rx practice with other top rx practices. Also, recently analyst placement has not been too great. Their bread and butter is m&a

Most Helpful
Dec 25, 2018 - 5:20pm
dedderss, what's your opinion? Comment below:

Jeez.. pretty harsh response. Their Rx analyst placement has been fantastic so not really sure what you are talking about. Also, the comment about Lazard is inaccurate as they also have placed very well in recent years.

Dec 22, 2018 - 4:42pm
Arnold Palmer, what's your opinion? Comment below:

Doesn't get as much love on this site because the analyst program isn't dedicated restructuring, which makes sense given the audience of WSO, but Moelis has killed restructuring in 2018. I'm positive they're first place in the bankruptcy league table by value, and maybe second by the number of engagements.

All the above listed are great shops. Some like Lazard are more debtor focussed vs HL which does more creditor work. As a rule of thumb, every firm does both, but different firms focus their practices differently. Debtor engagements tend to pay higher fees but in a restructuring, there's one debtor and often many creditors, so obviously fewer opportunities for debtor-side work.

The NYC bankruptcy world is very small. You see the same bankers and lawyers over and over again.

Dec 25, 2018 - 9:44pm
ijrhfbvwoirjnc, what's your opinion? Comment below:

Look at the Thomson Reuters league tables (ignore non-investment banks).

Q3 18: https://ibb.co/pQX6Zyn https://ibb.co/d7TwP4x

FY 17: https://ibb.co/qkmFSpc https://ibb.co/7KdDYvp

Dec 28, 2018 - 6:19pm
Ray Velcoro, what's your opinion? Comment below:

They don't do the same work as investment banks from a restructuring perspective. The consulting firms you see on the list typically focus on operational restructuring whereas the banks focus on financial restructuring. As a company, it is very common to hire both an operational advisor (an Alix/A&M/FTI/Zolfo) and a financial advisor (Laz/Moelis/HL/PJT).

We get the world we deserve.
  • 4
Dec 27, 2018 - 1:16pm
XSX82, what's your opinion? Comment below:

HL RX has placed well in LA from my understanding. Given their specialty in creditor side advisory, their analysts are exposed to numerous credit funds which bodes well for them. Furthermore, creditor side roles are less intense compared to debtor side roles. You will often times see Analysts balancing 4 or more creditor rx deals (more facetime with creditors) while debtor advisory may require an analysts full attention. I have always found debtor side advisory roles to be more fulfilling.

-XSX

Dec 27, 2018 - 1:42pm
u7o2q0qla4, what's your opinion? Comment below:

HL RX kills it. Moelis kills it. EVR kills it. PJT/LAZ kill it. They all place very well. Tbh any rx shop will kill it over the next few years as maturities need to be extended and overlevered sponsor backed companies file. Can't imagine a better group to be in given the current environment.

Dec 27, 2018 - 2:39pm
10x Leveraged, what's your opinion? Comment below:

I would disagree with your last given the following: 1.) Given the rising rate environment and brexit warnings since 2016, a lot of the refinancings and maturity extensions have already been executed in 2017 / 2018 2.) The vast majority (i'm talking like 85%+) of leveraged loans have been issued as covenant-lite or some sort of "covenant-loose" with a ridiculous headroom (think of like 40%+ assuming full RCF is drawn) so I would expect covenant breaches will be a lot lesser than you normally expect, even assuming we've reached the peak of the credit cycle and things head south starting next year

I do agree with your RX bank list - usually some combination of PJT / LAZ / HLHZ / EVR / Moelis when it comes to straight up dealflow. On a side note, some of the smartest kids I've ever met worked at PJT RX and Ducera RX, and they both absolutely loved their experiences for what it's worth.

Array

  • 6
  • 1
Dec 27, 2018 - 4:07pm
jay_ay_why, what's your opinion? Comment below:

What has EVR done that gets them a good reputation? I remember they got TXU but I thought perception was they didnt do the best job there (personally no opinion)

In terms of an overall practice I dont think they rank with Laz/HL/PJT but I guess the analyst program is different? Where have analysts landed from EVR Rx?

Dec 27, 2018 - 5:34pm
u7o2q0qla4, what's your opinion? Comment below:

Ipsam nesciunt quod eos. Corrupti unde officia sunt ad. Ducimus est nemo aut. Distinctio qui aut aliquam unde ullam consequatur.

Ad est commodi eligendi rerum odio. Aut aut molestias repellendus omnis aut.

Et vel ex ea sequi consequatur. Corporis aut soluta tempora est sit optio ullam. Et aut in repellat sint. Nihil voluptas architecto eum illo. Praesentium voluptatum alias cumque qui iusto. Distinctio consequatur voluptate et molestias voluptate et dolorem.

Molestiae et laborum non aut laborum et quasi. Aut commodi aut pariatur cum alias distinctio. Temporibus officiis sunt consequatur in nostrum enim. Voluptatem perferendis voluptatibus temporibus est.

Dec 27, 2018 - 11:54pm
edpollen12w, what's your opinion? Comment below:

Quibusdam magni quia libero necessitatibus sint est. Explicabo non aperiam est est voluptatem. Consequatur sed debitis et praesentium rerum.

Vel est voluptatibus unde. Tempore voluptate vel molestiae sed perferendis ut sit. Deserunt molestiae eaque inventore ut adipisci et ut. Nostrum corporis ad nostrum sit vel beatae sed. Ipsa aut iure rerum minima.

Start Discussion

Career Advancement Opportunities

August 2022 Investment Banking

  • Jefferies & Company (▲04) 99.6%
  • Lincoln International (= =) 99.2%
  • Bank of America Merrill Lynch (▲03) 98.8%
  • RBC Capital Markets (▲08) 98.4%
  • Macquarie Group Limited ABN (+ +) 98.0%

Overall Employee Satisfaction

August 2022 Investment Banking

  • Lincoln International (▲06) 99.6%
  • Jefferies & Company (▲11) 99.2%
  • Greenhill (▲07) 98.8%
  • PJT Partners (▽02) 98.4%
  • Macquarie Group Limited ABN (▲22) 98.0%

Professional Growth Opportunities

August 2022 Investment Banking

  • Lincoln International (▲04) 99.6%
  • Jefferies & Company (▲05) 99.2%
  • Bank of America Merrill Lynch (▲06) 98.8%
  • RBC Capital Markets (▲11) 98.4%
  • William Blair (▽01) 98.0%

Total Avg Compensation

August 2022 Investment Banking

  • Director/MD (10) $613
  • Vice President (37) $394
  • Associates (204) $256
  • 2nd Year Analyst (123) $163
  • 3rd+ Year Analyst (17) $156
  • 1st Year Analyst (389) $150
  • Intern/Summer Associate (79) $147
  • Intern/Summer Analyst (303) $92